Neogenomics (NEO) Liabilities from Discontinued Operations (2025)
Neogenomics' (NEO) quarterly Liabilities from Discontinued Operations came in at 478000.0 in Q3 2025, up 4.82% on a QoQ basis from 456000.0 in Q2 2025.
Neogenomics (NEO) Liabilities from Discontinued Operations (2025) Analysis & Trends
Neogenomics (NEO) has 1 years of Liabilities from Discontinued Operations data on file, last reported at 478000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | Neogenomics | 2.42 Bn | 2.28 Bn | 91.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 478,000.00 |
| Sep 30, 2025 | 478,000.00 |
| Jun 30, 2025 | 456,000.00 |
| Jun 30, 2025 | 456,000.00 |